SITA 50MG  TABDual action therapy: Sitagliptin enhances insulin release and reduces glucagon release, while Metformin suppresses hepatic glucose output and improves peripheral insulin sensitivity Proven to reduce HbAc, fasting, and postprandial glucose more than either component alone Improved treatment adherence due to simplified dosing regimen and fewer side effects than high dose monotherapy Dosage & Administration Recommended starting dose: 1 tablet twice daily